At4g21170 Antibody

What is At4g21170 and why are antibodies against it important?

At4g21170 encodes TIM17-1, a mitochondrial translocase of the inner membrane that plays a critical role during seed germination in Arabidopsis thaliana. Phenotypic analysis of T-DNA insertional mutants revealed that tim17-1 exhibits an increased rate of seed germination compared to wild-type plants . TIM17-1 appears to function in the temporal regulation of transcriptomic events during germination, with transcripts encoding biogenesis-related proteins peaking earlier and with greater magnitude in mutant backgrounds .

Antibodies against TIM17-1 are invaluable tools for:

• Tracking protein expression patterns during developmental transitions

• Confirming subcellular localization during organelle differentiation

• Validating protein-protein interactions within the mitochondrial import machinery

• Correlating transcript abundance with protein levels during biogenesis

What methods are used to generate and validate At4g21170 antibodies?

Generation of specific antibodies against TIM17-1 typically follows this workflow:

• Antigen design and production:

  • Expression of recombinant protein fragments or synthetic peptides from unique regions

  • Purification via affinity chromatography to ensure high antigen quality

  • Conjugation to carrier proteins for improved immunogenicity

• Antibody production:

  • Immunization of host animals (typically rabbits) with adjuvant formulations

  • Collection and purification of antisera via protein A/G chromatography

  • Affinity purification against the immunizing antigen

• Validation approaches:

  • Western blot analysis comparing wild-type and tim17-1 mutant tissues

  • Immunoprecipitation followed by mass spectrometry confirmation

  • Immunolocalization studies with appropriate controls

As noted in research materials, TIM17-1 antibody generation has been successfully performed to study mitochondrial biogenesis during seed germination .

How can I optimize At4g21170 antibody performance for Western blotting?

For optimal Western blot results with TIM17-1 antibodies:

• Sample preparation:

  • Extract total protein from plant tissues using buffers containing 1% Triton X-100

  • Include protease inhibitors to prevent degradation

  • For mitochondrial enrichment, perform differential centrifugation

• Electrophoresis conditions:

  • Use 12-15% polyacrylamide gels for optimal separation of TIM17-1 (~17 kDa)

  • Include positive controls (recombinant protein) and negative controls (tim17-1 mutant)

• Transfer and detection:

  • PVDF membranes are preferred for small proteins like TIM17-1

  • Blocking with 5% non-fat milk in TBS-T for 1 hour at room temperature

  • Primary antibody dilution: 1:1000-1:5000 (optimize for each antibody preparation)

  • Incubation overnight at 4°C provides optimal sensitivity

  • Secondary antibody: HRP-conjugated anti-rabbit IgG at 1:10,000 dilution

• Signal verification:

  • Expected band size: approximately 17 kDa

  • Verify specificity with tim17-1 mutant tissues (should show absent or reduced signal)

How can At4g21170 antibodies be used to study mitochondrial biogenesis during germination?

TIM17-1 antibodies provide powerful tools for investigating the dynamic changes in mitochondrial protein import machinery during germination:

• Temporal expression analysis:

  • Collect seed/seedling samples at defined timepoints (0, 6, 12, 24, 36, 48h after imbibition)

  • Perform Western blot analysis to quantify TIM17-1 protein levels

  • Correlate protein expression with transcript abundance using qRT-PCR data

  • Compare with other components of mitochondrial import machinery

• Organelle visualization:

  • Use immunofluorescence to track changes in mitochondrial morphology

  • Co-localize with other mitochondrial markers to assess organelle development

  • Document the transition from promitochondria to mature mitochondria, which is characterized by changes in size (0.5-2 μm) and morphology during germination

• Regulatory mechanisms:

  • Investigate the role of hormones in TIM17-1 expression

  • Promoter analysis has identified an ABA-responsive element (ABRE) in the TIM17-1 promoter that binds transcription factors which repress expression

  • Measure TIM17-1 protein levels in response to ABA and GA treatments

What considerations are important for co-immunoprecipitation with At4g21170 antibodies?

For successful co-immunoprecipitation experiments to identify TIM17-1 interaction partners:

• Optimization for membrane proteins:

  • Use gentle detergents (0.5-1% digitonin or 1% Triton X-100)

  • Include stabilizing agents (glycerol, specific lipids) in buffers

  • Consider crosslinking approaches for transient interactions

• Experimental controls:

  • Negative control: IgG from the same species as TIM17-1 antibody

  • Negative control: tim17-1 mutant tissue extracts

  • Positive control: Known interaction partners within TIM complex

• Protocol modifications for plant tissues:

  • Starting material: 1-2g of tissue (preferably germinating seeds)

  • Extraction buffer: 50mM Tris-HCl pH 7.5, 150mM NaCl, 1% Triton X-100, 10% glycerol, protease inhibitors

  • Pre-clear lysates with Protein A/G beads before antibody addition

  • Antibody amount: 2-5μg per mg of total protein

  • Incubation: Overnight at 4°C with gentle rotation

• Analysis approaches:

  • SDS-PAGE followed by silver staining or western blotting

  • Mass spectrometry for comprehensive interactome identification

  • Validation of key interactions through reciprocal co-IPs or yeast two-hybrid assays

How can genetic engineering approaches validate At4g21170 antibody specificity?

Several genetic approaches can confirm antibody specificity:

• CRISPR/Cas9 gene editing:

  • Generate frameshift mutations in TIM17-1 coding sequence

  • Create epitope-tagged versions of the endogenous protein

  • Western blotting should show band absence in knockouts or size shifts in tagged lines

• RNAi-mediated knockdown:

  • Establish lines with reduced TIM17-1 expression

  • Demonstrate corresponding reduction in antibody signal intensity

  • Quantify correlation between transcript and protein reduction

• Complementation studies:

  • Express TIM17-1 variants in mutant backgrounds

  • Confirm antibody recognition of the complemented protein

  • Use site-directed mutagenesis to identify critical epitope residues

How reliable are At4g21170 antibodies for quantitative protein expression analysis?

For quantitative applications of TIM17-1 antibodies:

• Signal linearity assessment:

  • Establish standard curves using recombinant TIM17-1 protein

  • Determine the linear range of antibody detection

  • Use fluorescent secondary antibodies for wider dynamic range

• Normalization approaches:

  • Select appropriate loading controls (preferably mitochondrial proteins)

  • Consider dual detection systems for simultaneous visualization

  • Include internal standards across blots for inter-experiment normalization

• Statistical considerations:

  • Minimum of three biological replicates

  • Technical replicates to assess method variability

  • Appropriate statistical tests for comparing expression levels

What protocols can detect post-translational modifications of At4g21170?

• Phosphorylation analysis:

  • Phosphatase treatment: Compare mobility with and without lambda phosphatase

  • Phos-tag™ SDS-PAGE for enhanced separation of phosphorylated forms

  • Phospho-specific antibodies if specific sites are identified

• Ubiquitination detection:

  • Denaturing immunoprecipitation to disrupt protein-protein interactions

  • Western blotting with anti-ubiquitin antibodies

  • Proteasome inhibitor treatment to accumulate modified forms

• Other modifications:

  • Mass spectrometry analysis of immunoprecipitated TIM17-1

  • 2D gel electrophoresis to separate modified forms

  • Chemical derivatization to detect specific modifications

How can At4g21170 antibodies help investigate hormonal regulation of mitochondrial biogenesis?

TIM17-1 represents an excellent model for studying hormonal control of organelle biogenesis:

• ABA/GA signaling connections:

  • Metabolomic analysis of tim17-1 mutants revealed significantly increased levels of ABA (2-fold) and GA (5-fold)

  • Promoter analysis identified ABA-responsive elements that repress TIM17-1 expression

  • Antibodies can track protein levels in response to hormone treatments

• Experimental approaches:

  • Treat germinating seeds with ABA, GA, or hormone biosynthesis inhibitors

  • Monitor TIM17-1 protein levels via western blotting

  • Correlate with mitochondrial development using microscopy

  • Compare wild-type and hormone signaling mutants

• Regulatory network analysis:

  • Use co-immunoprecipitation to identify hormone-dependent interactions

  • Compare TIM17-1 stability under different hormonal regimes

  • Investigate post-translational modifications in response to hormones

How can antibody-based approaches determine the functional relationship between TIM17-1 and other mitochondrial import components?

Understanding the integration of TIM17-1 within the mitochondrial protein import machinery:

• Comparative expression analysis:

  • Quantify the stoichiometry of TIM complex components during germination

  • Track expression patterns across developmental stages

  • Correlate with mitochondrial functional measurements

• Interaction mapping:

  • Sequential immunoprecipitation to identify subcomplexes

  • Proximity labeling approaches (BioID, APEX) with TIM17-1 as bait

  • Crosslinking mass spectrometry to identify direct binding interfaces

• Functional reconstitution:

  • In vitro import assays with immunodepleted mitochondria

  • Complementation with recombinant components

  • Structure-function analysis of TIM17-1 domains

Modern antibody engineering approaches, such as those described in genetic algorithm (GA) optimization methods, can potentially be applied to develop highly specific antibodies against challenging epitopes in TIM17-1 .

What emerging technologies can enhance At4g21170 antibody applications?

Several cutting-edge approaches hold promise for advancing TIM17-1 research:

• Single-molecule imaging:

  • Super-resolution microscopy (PALM, STORM) for nanoscale localization

  • Single-particle tracking to monitor dynamic behavior

  • FRET-based approaches to study protein-protein interactions in vivo

• Antibody engineering:

  • Development of recombinant antibody fragments (Fab, scFv)

  • Optimization through genetic algorithm (GA) approaches as described for other antibodies

  • Multi-specific antibodies to simultaneously track several import components

• Cryo-electron microscopy:

  • Structural analysis of TIM complexes with antibody fragments

  • Visualization of conformational changes during protein import

  • Integration with crosslinking mass spectrometry data

• In situ proximity labeling:

  • Antibody-directed enzymatic tagging (HRP, APEX2)

  • Spatially-restricted interactome mapping

  • Temporal analysis during germination and stress responses

These approaches can significantly advance our understanding of TIM17-1's role in mitochondrial biogenesis during seed germination and other developmental transitions.